Effect of Helicobacter pylori eradication on malignant transformation of gastric adenoma

Gastrointestinal Endoscopy

Volumn 52, Issue 1, 2000, Pages 27-32

  Saito, Kenichi ^a   Arai, Kazuko ^a   Mori, Masatomo ^a   Kobayashi, Ryouta ^a   Ohki, Ichiro ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE;

ADENOMA; AGED; ANTIBIOTIC THERAPY; ARTICLE; CANCER INHIBITION; DISEASE COURSE; ERADICATION THERAPY; FEMALE; FOLLOW UP; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH CANCER; TREATMENT OUTCOME;

EID: 0033914417     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1067/mge.2000.106112     Document Type: Article

References (39)

1. Yoshida S, Saito D. Gastric premalignancy and cancer screening in high-risk patients. Am J Gastroenterol. 89:1994;888-893.
2. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
3. Graham DY. Campylobacter pylori and peptic ulcer disease. Gastroenterology. 96:1989;615-625.
4. Waghorn DJ. Campylobacter pyloridis: a new organism to explain an old problem? Postgrad Med J. 63:1987;533-537.
5. Dooley CP, Cohen H, Fitzgibbons PL, Bauer M, Appleman MD, Perez GI. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med. 321:1989;1562-1566.
6. Craanen ME, Dekker W, Blok P, Ferwerda J, Tytgat GN. Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. Gut. 33:1992;16-20.
7. Correa P, Fox J, Fontham E, Ruiz B, Lin YP, Zavala D. Helicobacter pylori and gastric carcinoma: serum antibody prevalence in populations with contrasting cancer risks. Cancer. 66:1990;2569-2574.
8. Forman D, Newell DG, Fullerton F, Yarnell JW, Stacey AR, Wald N. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ. 302:1991;1302-1305.
9. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 325:1991;1127-1131.
10. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med. 325:1991;1132-1136.
11. Sipponen P, Kosunnen TU, Valie J. Helicobacter pylori infection and chronic gastritis in gastric cancer. J Clin Pathol. 45:1992;319-323.
12. Craanen ME, Blok P, Dekker W, Tytgat GN. Helicobacter pylori and early gastric cancer. Gut. 35:1994;1372-1374.
13. Lin JT, Wang LY, Wang JT, Wang TH, Chen CJ. Ecological study of association between Helicobacler pylori infection and gastric cancer in Taiwan. Dig Dis Sci. 40:1995;385-388.
14. Blaser MJ, Chyou PH, Nomura A. Age and establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res. 55:1995;562-565.
15. Asaka K, Kimura T, Kato M, Kudo M, Miki K, Ogoshi K. Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer. 73:1994;2691-2694.
16. O'Connor HJ. Helicobacler pylori and gastric cancer: a review and hypothesis. Eur J Gastroenterol Hepatol. 4:1992;103-109.
17. Loffeld RJ, Willems I, Flendrig JA, Arends JW. Helicobacter pylori and gastric carcinoma. Histopathology. 17:1990;537-541.
18. Talley, NJ,Zinsmeister, AR,Weaver, A1991Gastric adenocarcinoma Helicobacter pylori infection.J Natl Cancer Inst.
19. Endo S, Ohkusa T, Saito Y. Detection of Helicobacter pylori infection in early stage gastric cancer. Cancer. 75:1995;2203-2208.
20. Lyon: IARC. 1994;177-240.
21. Uemura N, Mukai T, Okamoto S, Yamaguchi S, Mashiba H, Taniyama K. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev. 6:1997;639-642.
22. Kohli Y, Kawai K, Fujita S. Analytical studies on growth of human gastric cancer. J Clin Gastroenterol. 3:1981;129-133.
23. Tsukuma H, Mishima T, Oshima A. Prospective study of "early" gastric cancer. Int J Cancer. 31:1983;421-426.
24. Yamazaki H, Oshima A, Murakami R, Endoh S, Ubukata T. A long-term follow-up study of patients with gastric cancer detected by mass screening. Cancer. 63:1989;613-617.
25. Komoto K, Haruma K, Kamada T, Tanaka S, Yoshihara M, Sumii K. Helicobacter pylori infection and gastric neoplasia: correlations with histological gastritis and tumor histology. Am J Gastroenterol. 93:1998;1271-1276.
26. Kokkola A, Monni O, Puolakkainen P, Nordling S, Haapiainen R, Kivilaakso E. Presence of high-level DNA copy number gains in gastric carcinoma and severely dysplastic adenomas but not in moderately dysplastic adenomas. Cancer Genet Cytogenet. 107:1998;32-36.
27. Goldstein NS, Lewin KJ. Gastric epithelial dysplasia and adenoma: historical review and histological criteria for grading. Hum Pathol. 28:1997;127-133.
28. El Hariry, Pignatelli M, Lemoine N. Fibroblast growth factor 1 and fibroblast growth factor 2 immunoreactivity in gastrointestinal tumours. J Pathol. 181:1997;39-45.
29. Park IC, Lee SH, Whang DY, Hong WS, Choi SS, Shin HS. Expression of a novel Bcl-2 related gene, Bfl-1, in various human cancers and cancer cell lines. Anticancer Res. 17:1997;4619-4622.
30. Nasu R, Mizuno M, Kiso T, Shimo K, Uesu T, Nasu J. Altered topographic expression of p21WAF1/CIP1/SDI1, bcl2 and p53 during gastric carcinogenesis. Pathol Res Pract. 194:1998;309-317.
31. Yoshihara M, Sumii K, Haruma K, Kiyohira K, Hattori N, Kitadai Y. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. Am J Gastroenterol. 93:1998;1090-1096.
32. Bajtai A, HidvÈgi J. The role of gastric mucosal dysplasia in the development of gastric carcinoma. Pathol Oncol Res. 4:1998;297-300.
33. Zhang QB, Dawodu JB, Husain A, Etolhi G, Gemmell CG, Russell RI. Association of antral mucosal levels of interleukin 8 and reactive oxygen radicals in patients infected with Helicobacter pylori. Clin Sci. 92:1997;69-73.
34. Uemura N, Oomoto Y, Mukai T, Okamoto S, Yamaguchi S, Mashiba H. Gastric corpus IL-8 concentration and neutrophil infiltration in duodenal ulcer patients. Aliment Pharmacol Ther. 11:1997;793-800.
35. Yamaoka, Y,Kodama, T,Graham, DY,Kashima, K1998Search for putative virulence factors of Helicobacter pylori: the lowmolecular-weight (33-35 K) antigen.Dig Dis Sci.
36. Konturek PC, Bielanski W, Bobrzynski A, Hahn EG, Konturek SJ. Gastric mucosal expression and luminal release of growth factors in gastric carcinoma and duodenal ulcer patients before and after eradication of Helicobacter pylori. J Physiol Pharmacol. 48:1997;375-382.
37. Uemura N, Okamoto S, Yamamoto S, Masuda H, Yamaguchi S, Mashiba H. Helicobacter pylori infection and gastric cancer: the effect of eradication [in Japanese with English abstract]. Endoscopia Digestiva. 10:1998;1077-1083.
38. Matsushita M, Hajiro K, Okazaki K, Takakuwa H. Endoscopic mucosal resection of gastric tumors located in the lesser curvature of the upper third of the stomach. Gastrointest Endosc. 45:1997;512-515.
39. Suzuki Y, Hiraishi H, Kanke K, Watanabe H, Ueno N, Ishida M. Treatment of gastric tumors by endoscopic mucosal resection with a ligating device. Gastrointest Endosc. 49:1999;192-199.